Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targeted CAR T-Cell Therapy for R/R MM - Ph1 Study Results"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Susan Bal
By
Insights from 2023 ASH Annual Meeting
FEATURING
Susan Bal
Login to view comments.
Click here to Login